Design and Synthesis of 1-Indol-1-yl-propan-2-ones as Inhibitors of Human Cytosolic Phospholipase A2α
摘要:
The synthesis and structure-activity relationship study of a series of 1-indol-1-yl-3-phenoxypropan-2-one inhibitors of cytosolic phospholipase A(2)alpha (cPLA(2)alpha) are described. The compounds were evaluated in a vesicle assay with isolated cPLA(2)alpha and in cellular assays with intact human platelets. Systematic variation led to 3-methylhydrogen 1-[3-(4-decyloxyphenoxy)-2-oxopropyl]indole-3,5-dicarboxylate (57), which revealed the highest activity against the isolated enzyme. With an IC50 value of 4.3 nM in this assay, it is one of the most potent in vitro cPLA(2)alpha inhibitors known today.
[DE] NEUE HETEROARYLSUBSTITUIERTE ACETONDERIVATE ALS HEMMSTOFFE DER PHOSPHOLIPASE A2 [EN] NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A2 [FR] NOUVEAUX DERIVES D'ACETONE A SUBSTITUTION HETEROARYLE SERVANT D'INHIBITEURS DE PHOSPHOLIPASE A2
[DE] NEUE HETEROARYLSUBSTITUIERTE ACETONDERIVATE ALS HEMMSTOFFE DER PHOSPHOLIPASE A2<br/>[EN] NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A2<br/>[FR] NOUVEAUX DERIVES D'ACETONE A SUBSTITUTION HETEROARYLE SERVANT D'INHIBITEURS DE PHOSPHOLIPASE A2
申请人:MERCKLE GMBH
公开号:WO2004069797A1
公开(公告)日:2004-08-19
Die Erfindung betrifft neuartige Heteroaryl-substituierte Acetonderivate welche das Enzym Phospholipase A2 hemmen, pharmazeutische Mittel, die diese Verbindungen enthalten und ein Verfahren zur Herstellung dieser Verbindungen.
Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2
申请人:Lehr Matthias
公开号:US20060142366A1
公开(公告)日:2006-06-29
The invention relates to novel heteroaryl substituted acetone derivatives which inhibit the enzyme phospholipase A
2
, pharmaceutical preparations containing these compounds and a method of producing these compounds.
Heteroaryl-substituted acetone derivatives as inhibitors of phospholipase A2
申请人:Merckle GmbH
公开号:US07608633B2
公开(公告)日:2009-10-27
The invention relates to novel heteroaryl substituted acetone derivatives which inhibit the enzyme phospholipase A2, pharmaceutical preparations containing these compounds and a method of producing these compounds.